Medical gases manufacturer, BOC Kenya, has reported a 170 per cent rise in profit after tax to Sh166 million for the six months to June 2025 from Sh61 million posted last year . This was largely driven by increased demand for medical and industrial gases and customer engineering projects that saw revenue increase by 38 per cent to Sh725 million, from Sh523 million a year prior.
Distribution, selling and administration expenses fell 1.8% from Sh165 million to Sh162 million due to management interventions to reduce costs.
The company has also had an opportunity to adjust its pricing as last year’s tenders come to an end, allow it to revise its pricing in line with increased costs.
“A pricing benefit is being realized in 2025 as various 2024 tenders come to an end, allowing the company to adjust its pricing to account for increased overhead,” The company said in the commentary section accompanying the interim results.
The company has retained its interim dividend at Sh2.50 per share, to be paid on or about 14th October 2025 to shareholders on the register at the close of business on 20th September 2025.
The company expects minimal change in performance in the second half of the year, as all engineering projects are likely to be completed before year-end.
BOC Kenya half year profits grew 170% to Sh166 million. —Revenue: +38% to 725M —Profit after tax: +170% to 166.7M —Earnings per share: +170% to Sh8.54 —Interim dividend: Sh2.50
